S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... حسب Sonsawan Sangprasert (22772538)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. حسب Luqiong Liu (11537092)

Changes in lactate/pyruvate ratio and ketone bodies ratio during CPB. حسب Vincent Pey (21433304)

الموضوعات:

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. حسب Katherine Schubert (5452712)

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. حسب Xiang-Fan Chen (13932983)

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. حسب Peiqi Yin (6533747)

Summary of significant single-arm time effect. حسب Wensheng Xiao (16557866)

Relation between training-related changes in unipedal and bipedal stance. حسب Cristina Dolciotti (16317330)

الموضوعات:

Reducing Dscam1 diversity decreases adult lifespan in a cluster-specific manner, also see S6 and S7 Figs. حسب Haiyang Dong (4783608)

Potato gene ontology enrichment results significant at <i>p</i> < 0.01. حسب Margaret A. Carpenter (6104180)

Cohesiveness changes across IDDSI levels and food categories. حسب Muxi Chen (9294270)

الموضوعات:

Impact of the NAMR on CSR dimensions (E, S, G). حسب Le Zhu (1771669)

الموضوعات:

Placebo test. حسب Le Zhu (1771669)

الموضوعات:

Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. حسب Qian Cai (112039)

الموضوعات:

The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. حسب Qian Cai (112039)

الموضوعات:

Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. حسب Qian Cai (112039)

الموضوعات:

Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. حسب Qian Cai (112039)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. حسب Filip Stanicic (17808254)

الموضوعات: